GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kelyniam Global Inc (OTCPK:KLYG) » Definitions » ROCE %

Kelyniam Global (Kelyniam Global) ROCE % : 0.00% (As of Mar. 2008)


View and export this data going back to 2008. Start your Free Trial

What is Kelyniam Global ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kelyniam Global's annualized ROCE % for the quarter that ended in Mar. 2008 was 0.00%.


Kelyniam Global ROCE % Historical Data

The historical data trend for Kelyniam Global's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kelyniam Global ROCE % Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
ROCE %
-1,316.67 -

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
ROCE % Get a 7-Day Free Trial 307.69 - - - -

Kelyniam Global ROCE % Calculation

Kelyniam Global's annualized ROCE % for the fiscal year that ended in Dec. 2007 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2007 )  (A: Dec. 2006 )(A: Dec. 2007 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2007 )  (A: Dec. 2006 )(A: Dec. 2007 )
=-0.173/( ( (0.084 - 0.078) + (0.068 - 0.117) )/ 2 )
=-0.173/( (0.006+-0.049)/ 2 )
=-0.173/-0.0215
=804.65 %

Kelyniam Global's ROCE % of for the quarter that ended in Mar. 2008 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2008 )  (Q: Dec. 2007 )(Q: Mar. 2008 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2008 )  (Q: Dec. 2007 )(Q: Mar. 2008 )
=-0.232/( ( (0.068 - 0.117) + (0.063 - 0.124) )/ 2 )
=-0.232/( ( -0.049 + -0.061 )/ 2 )
=-0.232/-0.055
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2008) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kelyniam Global  (OTCPK:KLYG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Kelyniam Global ROCE % Related Terms

Thank you for viewing the detailed overview of Kelyniam Global's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kelyniam Global (Kelyniam Global) Business Description

Traded in Other Exchanges
N/A
Address
97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc is a medical device manufacturing company that specializes in the production of custom skull implants utilizing computer-aided design and bio-compatible medical grade polymers.

Kelyniam Global (Kelyniam Global) Headlines